Composition
- Active ingredients
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleThis page
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 250MG BASE · CapsuleNDA050512-002 · Discontinued
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For suspensionNDA050527-003 · Discontinued
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 500MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For suspensionNDA050527-001 · Discontinued
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · For suspensionNDA050527-002 · Discontinued
- CEFADROXIL/CEFADROXIL HEMIHYDRATE EQ 1GM BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA050528-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA050512.
At a glance
- Brand name
- Duricef
- Active substance
- cefadroxil/cefadroxil hemihydrate
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Warner Chilcott
- Status
- Discontinued
- FDA approval
- 17 Feb 1978
- Application
- NDA050512-001